Brain metabolite composition in relation to cognitive function and dystrophin mutations in boys with Duchenne muscular dystrophy
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Duchenne muscular dystrophy (DMD) is a hereditary X‐linked recessive disorder affecting the synthesis of dystrophin, a protein essential for structural stability in muscle. Dystrophin also occurs in the central nervous system, particularly in the neocortex, hippocampus and cerebellum. Quantitative metabolic analysis by localized 1 H MRS was performed in the cerebellum (12 patients and 15 controls) and a temporo‐parietal location (eight patients and 15 controls) in patients with DMD and healthy controls to investigate possible metabolic differences. In addition, the site of individual mutations on the dystrophin gene was analyzed and neuropsychological cognitive functions were examined. Cognitive deficits in the patient group were found in line with earlier investigations, mainly concerning verbal short‐term memory, visuo‐spatial long‐term memory and verbal fluency, but also the full‐scale IQ. Causal mutations were identified in all patients with DMD. Quantitative MRS showed consistent choline deficits, in both cerebellar white matter and temporo‐parietal cortex, as well as small, but significant, metabolic abnormalities for glutamate and total N ‐acetyl compounds in the temporo‐parietal region. Compartment water analysis did not reveal any abnormalities. In healthy subjects, choline levels were age related in the cerebellum. The choline deficit contrasts with earlier findings in DMD, where a surplus of choline was postulated for the cerebellum. In patients, total N ‐acetyl compounds in the temporo‐parietal region were related to verbal IQ and verbal short‐term memory. However, choline, the putative main metabolic abnormality, was not found to be associated with cognitive deficits. Furthermore, in contrast with the cognitive performance, the metabolic brain composition did not depend significantly on whether or not gene mutations concerned the expression of the dystrophin isoform Dp140, leading to the conclusion that the effect of the missing Dp140 isoform on cognitive performance is not mediated through the observed metabolite composition, or is caused by local effects beyond the resolution accessible to MRS investigations. Copyright © 2010 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Proton spectra studies have reported conflicting data, with both increased and decreased choline compounds observed in different brain regions (cerebellum, hippocampus, and frontal and temporoparietal regions) (Rae et al., 1998; Kreis et al., 2011; Doorenweerd et al., 2017b).”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Kreis et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular energetics of dystrophic muscle
Kemp, G. J., Taylor, D. J., Dunn, J. F., Frostick, S. P., & Radda, G. K. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90326-t · Cited by 125
Research works printed but not linked: 40
- 10.1016/S0165-0173(99)00090-9 · DOI · Paper page
- 10.1093/brain/awf012 · DOI · Paper page
- 10.1016/0960-8966(94)90072-8 · DOI · Paper page
- Emery AEH, 1993, Oxford Monographs on Medical Genetics, 24
- 10.1111/j.1469-8749.2005.tb01131.x · DOI
- 10.1080/09297040802665777 · DOI · Paper page
- 10.1371/journal.pone.0004347 · DOI · Paper page
- 10.1073/pnas.89.16.7506 · DOI
- 10.1038/sj.ejhg.5200488 · DOI
- 10.1371/journal.pone.0008803 · DOI · Paper page
- 10.1111/j.1469-8749.1995.tb12000.x · DOI
- Wingeier K, 2010, Duchenne muscular dystrophy: neuropsychological impairments and the impact of different dystrophin mutations on general cognitive functioning, J. Clin. Neurosci.
- 10.1111/j.1469-8749.2007.00123.x · DOI
- 10.1016/j.bandl.2007.02.003 · DOI
- 10.1111/j.1469-8749.2004.tb00466.x · DOI
- 10.1076/chin.4.2.110.3183 · doi:10.1076/chin.4.2.110.3183
- 10.1098/rspb.1993.0030 · DOI
- 10.1016/S0960-8966(98)00049-2 · DOI
- 10.1093/brain/122.1.121 · DOI
- 10.1016/S0140-6736(95)90923-0 · DOI
- 10.1016/0022-510X(96)00135-9 · DOI
- 10.1016/S0022-510X(98)00190-7 · DOI · Paper page
- 10.1097/00001756-199704140-00022 · doi:10.1097/00001756-199704140-00022
- 10.1002/mus.10238 · DOI · Paper page
- 10.1002/mrm.10246 · DOI
- VermathenP BoeschC KreisR. A novel tissue segmentation method for metabolite quantitation from MRSI data.Proceedings of the 20th Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology Rotterdam the Netherlands 2003;330.
- 10.1002/mrm.21422 · DOI
- 10.1002/mrm.1910300604 · DOI · Paper page
- 10.1002/mrm.1269 · DOI
- 10.1006/jmrb.1993.1056 · DOI · Paper page
- 10.1002/nbm.891 · DOI · Paper page
- 10.1002/mrm.1910330603 · doi:10.1002/mrm.1910330603
- 10.1016/S0960-8966(01)00253-X · DOI · Paper page
- 10.1203/00006450-199910000-00019 · DOI · Paper page
- 10.1002/mrm.1248 · DOI
- 10.1002/(SICI)1097-4598(199910)22:10<1367::AID-MUS5>3.0.CO;2-H · DOI · Paper page
- 10.1006/abio.2001.5096 · DOI
- 10.1002/nbm.1419 · DOI
- Subcommittee on Upper Reference Levels of Nutrients Food and Nutrition Board Institute of Medicine. Choline. In Dietary Reference Intakes for Thiamin Riboflavin Niacin Vitamin B6 Folate Vitamin B12 Pantothenic Acid Biotin and Choline. National Academy Press: Washington 1998;390–422.
- 10.1016/j.neubiorev.2007.09.001 · DOI
Cited by
Understanding Duchenne muscular dystrophy-associated brain pathology
Verhaeg, M. A. T., Govaarts, R., & van Putten, M. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052302 · Cited by 5
Metadata
- Authors
- Kreis, R., Wingeier, K., Vermathen, P., Giger, E., Joncourt, F., Zwygart, K., Kaufmann, F., Boesch, C., & Steinlin, M.
- Venue
- NMR in Biomedicine
- Publisher
- Wiley
- Published
- 2010-12-07
- Volume
- 24
- Issue
- 3
- Pages
- 253-262
- ISSN
- 0952-3480
- 1099-1492
- Cited by
- 40
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.